Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Controlled, Double-blind Study to Evaluate the Efficacy and Tolerability of a Steroid/Antibiotic Associated Treatment Following Cataract Extraction by Means of Phaco-emulsification

NCT02973880 is registered in ClinicalTrials.gov with SIFI SpA as lead sponsor.

NCT NCT02973880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02973880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Controlled, Double-blind Study to Evaluate the Efficacy and Tolerability of a Steroid/Antibiotic Associated Treatment Following Cataract Extraction by Means of Phaco-emulsification
Lead sponsor
SIFI SpA
Phase
Phase 3
Overall status
Completed
Start date
October 15, 2017
Completion date
December 30, 2018
Enrollment
180 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cataract, cataract extraction